Log in to save to my catalogue

EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells

EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7601546

EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells

Publication information

Publisher

Tehran: Pasteur Institute of Iran

More information

Scope and Contents

Contents

Background: Epithelial ovarian cancer (EOC) is one of the most lethal gynecological malignancy worldwide. Although the majority of EOC patients achieve clinical remission after induction therapy, over 80% relapse and succumb to the chemoresistant disease. Previous investigations have demonstrated the association of epidermal growth factor receptor...

Alternative Titles

Full title

EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7601546

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7601546

Other Identifiers

ISSN

1028-852X

E-ISSN

2008-823X

DOI

10.29252/ibj.24.6.365

How to access this item